Skip to main content

Want a detailed portfolio tracker?

Mimedx Group (MDXG) P/E (2011 - 2026)

Mimedx Group (MDXG) P/E from Mar 31, 2011 to Jul 21, 2026. The TTM Mimedx Group (MDXG) P/E is 20.79. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Mimedx Group (MDXG)

YearP/EChange
202620.79+0.81%
202520.62-38.12%
202433.33-85.99%
2023237.83-2175.05%
2022-11.46-82.49%
2021-65.45+221.11%
2020-20.38-37.58%
2019-32.66+397.23%
2018-6.57-111.07%
201759.33+23.14%
201648.18+39.99%
201534.42-82.76%
2014199.66-195.22%
2013-209.68+391.24%
2012-42.68+328.78%
2011-9.95N/A

Comparison Mimedx Group (MDXG) P/E with competitors

Mimedx Group (MDXG) P/E is 20.79.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.99%
NBYStablecoin Development Corp0.00-99.98%
ENLVEnlivex Ltd0.07-99.64%
FGENFibroGen Inc0.24-98.85%
CHRSCoherus Biosciences Inc0.85-95.92%
FBIOFortress Biotech Inc0.95-95.44%
ORMPOramed Pharmaceuticals Inc1.50-92.77%
AGENAgenus Inc3.01-85.52%
INVAInnoviva Inc3.15-84.83%
VXRTVaxart Inc3.55-82.93%
CRMDCorMedix Inc3.63-82.55%
CVACCureVac N.V.4.45-78.62%
GLPGGalapagos NV4.86-76.63%
SRPTSarepta Therapeutics Inc4.88-76.52%
ABEOAbeona Therapeutics Inc5.39-74.09%
ABUSArbutus Biopharma Corp5.60-73.08%
ZVRAZevra Therapeutics Inc5.89-71.68%
SPROSpero Therapeutics Inc6.23-70.04%
CGENCompugen Ltd6.31-69.63%
RIGLRigel Pharmaceuticals6.87-66.95%
SLXNSilexion Therapeutics Corp7.30-64.91%
OMEROmeros Corporation9.26-55.47%
AUPHAurinia Pharmaceuticals Inc9.58-53.90%
PLXProtalix BioTherapeutics Inc10.89-47.61%
ACADAcadia Pharmaceuticals Inc11.73-43.59%
TBPHTheravance Biopharma Inc12.26-41.02%
ADMAAdma Biologics Inc12.42-40.27%
HRMYHarmony Biosciences Holdings Inc13.82-33.52%
SABSSAB Biotherapeutics Inc14.14-32.00%
NAGENiagen Bioscience Inc14.82-28.72%
INCYIncyte Corp15.82-23.89%
REGNRegeneron Pharmaceuticals Inc15.86-23.73%
PBYIPuma Biotechnology Inc17.32-16.71%
CPRXCatalyst Pharmaceuticals Inc17.44-16.12%
EXELExelixis Inc17.54-15.64%
TGTXTG Therapeutics Inc18.97-8.77%
XOMAXOMA Royalty Corp22.87+10.03%
ARGXArgen X SE24.30+16.88%
CTMXCytomX Therapeutics Inc24.82+19.39%
XOMAOXOMA Royalty Corp25.34+21.91%
HALOHalozyme Therapeutics Inc25.62+23.25%
XOMAPXOMA Royalty Corp25.67+23.48%
VRTXVertex Pharmaceuticals Inc27.99+34.66%
RPRXRoyalty Pharma plc - Class A28.69+37.99%
SLNOSoleno Therapeutics Inc29.02+39.57%
ASNDAscendis Pharma A/S30.09+44.72%
LGNDLigand Pharmaceuticals Inc - Class B37.91+82.36%
APLSApellis Pharmaceuticals Inc39.02+87.70%
BMRNBiomarin Pharmaceutical Inc42.21+103.05%
KRYSKrystal Biotech Inc45.34+118.11%
ONCBeiGene Ltd69.54+234.50%
PHARPharming Group N.V.75.03+260.89%
TECHBio-Techne Corp101.96+390.44%
VCELVericel Corp109.92+428.74%
ALNYAlnylam Pharmaceuticals Inc117.96+467.43%
GMABGenmab140.29+574.82%
TLXTelix Pharmaceuticals Ltd162.15+679.98%
CORTCorcept Therapeutics Inc212.86+923.88%